申请人:Board of Regents, The University of Texas System
公开号:US20220177891A1
公开(公告)日:2022-06-09
Method of treating cancer, such as a metastatic cancer, with inhibitors of homeodomain interacting protein kinase 4 (HIPK4) are provided. Related therapeutic compositions are also disclosed.